Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
01 October 2019 | Story Nikile Ntsababa (Registrar)

The nomination process for the election of two representatives to serve on the UFS Council was finalised on Tuesday, 17 September 2019 – the closing date for nominations.
 
Here are the names of the nominees (listed alphabetically):
 
Representative from the Qwaqwa Campus:
None
 
Other representative:
Mr Christo Dippenaar
Dr Pieter du Toit
Mr Lefa Mabaso
Dr Walter Matli
Mr Zama Sigwebela
 
Please note that no nominations were received for representatives from the Qwaqwa Campus.  Since this scenario is not legislated in the Statute, Institutional Rules, and Convocation Constitution, the Registrar will, after consultation with the President of the Convocation, open another round of nominations for Qwaqwa representatives to Council (with the closing date 8 October 2019) to ensure that the campus is also represented on Council.
 
Convocation and Alumni members from the Qwaqwa Campus are therefore given a second opportunity to nominate one representative from among their members for the Qwaqwa Campus.  All nominations must reach the office of the Registrar no later than 16:30 on Wednesday, 9 October 2019.
 
Every nomination form  shall be signed by four (4) members of the Convocation and shall contain the written acceptance of the nomination by the nominee under his/her signature as well as an abridged CV and a motivation of more or less 200 words.
 
Nominations are to be submitted to:  email: registrar@ufs.ac.za or delivered by hand to Nikile Ntsababa, Main Building, Room 51, Bloemfontein Campus.
 
Kindly take note that late or incomplete nominations will not be accepted or considered.
 
Further information regarding the election process will follow in due course.

News Archive

Otorhinolaryngology research hopes to decrease morbidity
2016-10-04

Description: Prof Riaz Seedat Tags: Prof Riaz Seedat

Prof Riaz Seedat, Head of the
Department of
Otorhinolaryngology at the UFS

Prof Riaz Seedat, Head of the Department of Otorhinolaryngology at the UFS is a world-renowned ear, nose and throat specialist and researcher. He is also a National Research Foundation C3 rated scientist.

He is conducting his research in ear, nose and throat (ENT) pathology in a developing world setting, particularly focusing on recurrent respiratory papillomatosis and other ENT conditions. “This condition is caused by human papillomavirus (HPV), infective conditions as well as allergic rhinitis,” said Prof Seedat.

Current research is aimed at further describing the epidemiology of recurrent respiratory papillomatosis, identification of the HPV variants responsible for causing the condition and markers of disease aggressiveness.

The research has led to various international partnerships such as the multicentre collaborative studies, “Genetic Susceptibility to Papilloma-induced Voice Disturbance” at the Centre for Genomic Sciences at the Allegheny-Singer Research Institute in Pittsburgh, United States, and the HPV6/11 Global Diversity Consortium at the University of Ljubljana in Slovenia.

Although most head and neck squamous cell carcinomas are caused by excessive tobacco and alcohol use, there is an increasing body of evidence to show that HPV causes a subset of head and neck squamous cell carcinomas. However, there are few studies on the role of HPV in head and neck neoplasms in developing countries.

“Through the research we have shown that recurrent respiratory papillomatosis, caused by HPV, is not as rare in South Africa as it is in developed countries and that patients usually present respiratory papillomatosis at an advanced stage when the condition is life-threatening,” said Prof Seedat.

“It is hoped that this research will help us to address the morbidity caused by ENT conditions common in developing countries,” said Prof Seedat.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept